HILLSDALE INVESTMENT MANAGEMENT INC. Corcept Therapeutics Incorporated Transaction History

HILLSDALE INVESTMENT MANAGEMENT INC. portfolio value:

$5.77M
portfolio value

HILLSDALE INVESTMENT MANAGEMENT INC. quarter portfolio value change:

+7.82%
quarter

Corcept Therapeutics Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -9.48% -23.6K shares -143K $25.64 225.4K
Q2 2022 share Increase +0.57% 1.4K shares 346K $23.78 249K
Q1 2022 share Increase 0.00% 247.6K shares 5.57M $22.52 247.6K
Q4 2020 share Decrease -100.00% -185.4K shares -3.22M $26.16 0
Q3 2020 share 0.00% 0 shares 107K $17.41 185.4K
Q2 2020 share Increase 0.00% 185.4K shares 3.11M $16.82 185.4K
Q2 2018 share Decrease -100.00% -80.3K shares -1.32M $15.72 0
Q1 2018 share Decrease -11.07% -10K shares -310K $16.45 80.3K
Q4 2017 share 0.00% 0 shares -112K $18.06 90.3K
Q3 2017 share 0.00% 0 shares 677K $19.3 90.3K
Q2 2017 share Decrease -12.58% -13K shares -66K $11.8 90.3K
Q1 2017 share Increase 0.00% 103.3K shares 1.13M $10.96 103.3K